Studi basati su riscontri empirici e White Paper

Establishing an Anticoagulation “Drive Through” Clinic during the COVID-19 Pandemic using the LumiraDx Platform INR Test

An evaluation of the detection of SARS-CoV-2 antigen in a cohort of symptomatic and asymptomatic patients: Report from the evaluation of SKUP

Performance evaluation of the LumiraDx SARS-CoV-2 Antigen Test to aid diagnosis of acute COVID-19 at the point of care

Evaluation of the Accuracy of the LumiraDx INR Test Using Patients in Receipt of Phenprocoumon Anticoagulation Therapy

Evaluation of the Accuracy of INR values measured by a POCT system in a German Clinic with patients taking Phenprocoumon as VKA Therapy.

Laboratory accuracy assessment of a novel INR Point-of-Care Test compared with laboratory reference methods used across four independent clinical sites.

Evaluation der Genauigkeit von LumiraDx INR-Messwerten bei Patienten unter Phenprocoumon-Therapie.

Sensitivity of LumiraDx INR Testing to Interference from Antiphospholipid Antibodies (aPL)

The LumiraDx Platform INR Test: Performance and ease of use in an anticoagulation clinic setting

LumiraDx INR Test: Laboratory Accuracy Assessment with the ACL Elite and Sysmex Reference Methods

Valutazione di LumiraDx Platform e del test INR presso lo studio medico dei Dott.ri Schreiber, Steinbauer e Dechant

Performance of the LumiraDx Platform INR Test in a point-of-care setting compared to an established laboratory reference method

Point of care testing in primary care in Europe: Improving pathways and patient outcomes

Point-of-care testing in the community pharmacy – improving access to care.

Summary of the Evaluation of 32 rapid tests for detection of IgG antibodies against SARS-CoV-2 (NOKLUS)